Figure 7

Illustration of Study Design. Dogs with naturally occuring infections were selected for treatment with activated canine allogeneic MSC according to inclusion and exclusion criteria explained in methods. The wounds were quantitatively cultured prior to the start of treatment and every 2 weeks prior to MSC injection. Dogs were evaluated 2 weeks after the last treatment and a culture performed at that time. Dogs were kept on the antibiotic they were taking prior to enrollment in the trial for the length of the trial.